Glucagon-like peptide receptor agonists (GLP-1RAs) like Novo Nordisk’s semaglutide (Ozempic, Wegovy) and Eli Lilly’s ...
US President Donald Trump has signalled plans to impose a 25% tariff on car imports, along with similar or higher levies on ...
The grant, given by the European Union’s Innovative Health Initiative (EU-IHI), was awarded to Bar-Ilan University’s Dr. Sivan Spitzer, along with a team of researchers from six EU countries. The ...
Tariffs targeted at countries — reciprocal or regular — will likely be paid by multinational companies, dampening the outlook ...
Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...
Where could be the top place to invest this spring? Europe. That's according to the latest edition of the hugely influential ...
Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...
Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...
Deutsche Bank analyst Emmanuel Papadakis maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...
Ancient DNA is telling us more and more about humans and environments long past. Could it also help rescue the future?
We recently compiled a list of the 13 Best Foreign Dividend Stocks To Buy According to Analysts. In this article, we are ...
Ascendis Pharma AS (ASND) reports significant milestones and market traction, despite facing revenue and reimbursement hurdles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results